Revision of the ADA-classification of diabetes mellitus type 2 (DMT2): The importance of maturity onset diabetes (MOD), and senile diabetes (DS)

Archives of Gerontology and Geriatrics

Volumn 53, Issue 1, 2011, Pages 113-119

  Vacante, Marco ^a   Malaguarnera, Michele ^a   Motta, Massimo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Diabetes mellitus type 2; Maturity onset diabetes; Maturity onset diabetes in elderly; Senile diabetes

Indexed keywords

ADAMTS9 PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR 2A; G PROTEIN COUPLED RECEPTOR; GLUCOSE; HEMOGLOBIN A1C; HOMEODOMAIN PROTEIN; INSULINASE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; KINESIN; METALLOPROTEINASE; NOTCH2 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SOMATOMEDIN BINDING PROTEIN 2; TETRASPANIN; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADAMTS9 GENE; AGING; ARTICLE; CAMK1D GENE; CDC123 GENE; CDKAL1 GENE; CDKN2A GENE; CDKN2B GENE; CHRONIC DISEASE; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; FTO GENE; GENE CONTROL; GENE LOCUS; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEREDITY; HHEX GENE; HUMAN; HYPERGLYCEMIA; IDE GENE; IGFBP2 GENE; JAZF1 GENE; KCJN11 GENE; KIF11 GENE; LGR5 GENE; LIFESPAN; LIFESTYLE; LONGEVITY; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTCH2 GENE; OBESITY; ONSET AGE; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PPARG GENE; PREVALENCE; PRIORITY JOURNAL; SENILE DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; SLC30A8 GENE; SOCIOECONOMICS; TCF7L2 GENE; THADA GENE; TSPAN8 GENE;

AGED; AGED, 80 AND OVER; AGING; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE;

EID: 79957985721     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2010.06.017     Document Type: Article

References (74)

1. ADA (American diabetes Association) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
2. ADA (American diabetes Association) Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
3. Agalliu I., Salinas C.A., Hansten P.D., Ostrander E.A., Stanford J.L. Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am. J. Epidemiol. 2008, 168:250-260.
4. Bouhaha R., Choquet H., Meyre D., Abid Kamoun H., Ennafaa H., Baroudi T., Sassi R., Vaxillaire M., Elgaaied A., Froguel P., Cauchi S. TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia. Pathol. Biol. (Paris) 2009, March 13 (Epub ahead of print).
5. Burwinkel B., Shanmugam K.S., Hemminki K., Meindl A., Schmutzler R.K., Sutter C., Wappenschmidt B., Kiechle M., Bartram C.R., Frank B. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer 2006, 6:268.
6. Capri M., Salvioli S., Sevini F., Valensin S., Celani L., Monti D., Pawelec G., De Benedictis G., Gonos E.S., Franceschi C. The genetics of human longevity. Ann. N. Y. Acad. Sci. 2006, 1067:252-263.
7. Carnazzo G., Rosso D., Di Stefano F., Corrao G., Giarelli L., Bussani R., Motta L. Pathological lesions in senile diabetes: possible pathogenetic interpretations. Arch. Gerontol. Geriatr. 1996, 22(Suppl. 1):239-244.
8. Cauchi S., Vaxillaire M., Choquet H., Durand E., Duval A., Polak M., Froguel P. No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects. Diabetologia 2007, 50:214-216.
9. Cauchi S., El Achhab Y., Choquet H., Dina C., Krempler F., Weitgasser R., Nejjari C., Patsch W., Chikri M., Meyre D., Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J. Mol. Med. 2007, 85:777-782.
10. Cauchi S., Choquet H., Gutiérrez-Aguilar R., Capel F., Grau K., Proença C., Dina C., Duval A., Balkau B., Marre M., Potoczna N., Langin D., Horber F., Sørensen T.I., Charpentier G., Meyre D., Froguel P. Effects of TCF7L2 polymorphisms on obesity in European populations. Obesity (Silver Spring) 2008, 16:476-482.
11. Dahlgren A., Zethelius B., Jensevik K., Syvänen A.C., Berne C., Cohort ULSAM. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men. Diabetologia 2007, 50:1852-1857.
12. Doria A., Wojcik J., Xu R., Gervino E.V., Hauser T.H., Johnstone M.T., Nolan D., Hu F.B., Warram J.H. Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. J. Am. Med. Assoc. 2008, 300:2389-2397.
13. Doria A., Patti M.E., Kahn C.R. The emerging genetic architecture of type 2 diabetes. Cell Metab. 2008, 8:186-200.
14. Duan Q.L., Dubé M.P., Frasure-Smith N., Barhdadi A., Lesperance F., Théroux P., St-Onge J., Rouleau G.A., McCaffery J.M. Additive effects of obesity and TCF7L2 variants on risk for type 2 diabetes among cardiac patients. Diabetes Care 2007, 30:1621-1623.
15. European Diabetes Working Party for Older People 2001-2004 Clinical Guidelines for Type 2 Diabetes Mellitus 2004.
16. Field S.F., Howson J.M., Smyth D.J., Walker N.M., Dunger D.B., Todd J.A. Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects. Diabetologia 2007, 50:212-213.
17. Florez J.C. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?. Diabetologia 2008, 51:1100-1110.
18. Folsom A.R., Pankow J.S., Peacock J.M., Bielinski S.J., Heiss G., Boerwinkle E. Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 2008, 31:905-909.
19. Gavin J.R. New classification and diagnostic criteria for diabetes mellitus. Diabetes 1998, 1:3.
20. Grant R.W., Meigs J.B. Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction. Diabetes Care 2007, 30:479-484.
21. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K.P., Walters G.B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R.L., Reilly M.P., Rader D.J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J.R., Kong A., Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 2006, 38:320-323.
22. Grant R.W., Moore A.F., Florez J.C. Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care 2009, 32:1107-1114.
23. Guo T., Hanson R.L., Traurig M., Muller Y.L., Ma L., Mack J., Kobes S., Knowler W.C., Bogardus C., Baier L.J. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3501 individuals. Diabetes 2007, 56:3082-3088.
24. Hales C.N., Barker D.J., Clark P.M., Cox L.J., Fall C., Osmond C., Winter P.D. Fetal and infant growth and impaired glucose tolerance at age 64. Br. Med. J. 1991, 303:1019-1022.
25. Haupt A., Staiger H., Schäfer S.A., Kirchhoff K., Guthoff M., Machicao F., Gallwitz B., Stefan N., Häring H.U., Fritsche A. The risk allele load accelerates the age-dependent decline in beta cell function. Diabetologia 2009, 52:457-462. (Epub 2009 January 27).
26. Helgason A., Pálsson S., Thorleifsson G., Grant S.F., Emilsson V., Gunnarsdottir S., Adeyemo A., Chen Y., Chen G., Reynisdottir I., Benediktsson R., Hinney A., Hansen T., Andersen G., Borch-Johnsen K., Jorgensen T., Schäfer H., Faruque M., Doumatey A., Zhou J., Wilensky R.L., Reilly M.P., Rader D.J., Bagger Y., Christiansen C., Sigurdsson G., Hebebrand J., Pedersen O., Thorsteinsdottir U., Gulcher J.R., Kong A., Rotimi C., Stefánsson K. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat. Genet. 2007, 39:218-225.
27. International Diabetes Federation Diabetes Atlas Second Edition 2003, International Diabetes Federation, Brussels, www.eatlas.idf.org.
28. Ionescu Tirgoviste C What can we expect from genetic analysis of type 2 diabetes in the near future?. Int. J. Metab. 2005, by Fax 8, 28. http://www.servier.com/Pro/Diabetes/JournalByFax/AllIssues.aspx.
29. Ionescu Tirgoviste C. TCF7L2: a new piece in the genetic architecture of type 2 diabetes. Int. J. Metab. 2007, by Fax, 10, 9. http://www.servier.com/Pro/Diabetes/JournalByFax/AllIssues.aspx.
30. Jin T., Liu L. The Wnt signaling pathway effector TCF7L2 and type II diabetes mellitus. Mol. Endocrinol. 2008, 22:2383-2392.
31. Kovacs P., Berndt J., Ruschke K., Klöting N., Schön M.R., Körner A., Stumvoll M., Blüher M. TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus. Metabolism 2008, 57:1227-1231.
32. Köttgen A., Hwang S.J., Rampersaud E., Coresh J., North K.E., Pankow J.S., Meigs J.B., Florez J.C., Parsa A., Levy D., Boerwinkle E., Shuldiner A.R., Fox C.S., Kao W.H. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J. Am. Soc. Nephrol. 2008, 19:1989-1999.
33. Lango H., Palmer C.N., Morris A.D., Zeggini E., Hattersley A.T., McCarthy M.I., Frayling T.M., Weedon M.N. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 2008, 57:3129-3135.
34. Lio D., Malaguarnera M., Maugeri D., Ferlito L., Bennati E., Scola L., Motta M., Caruso C. Laboratory parameters in centenarians of Italian ancestry. Exp. Gerontol. 2008, 43:119-122.
35. Liu Z., Habener J.F. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J. Biol. Chem. 2008, 28:8723-8735.
36. Lombardo A., Oliva G., Scornavacca G., Cacciola R., Motta M., Coppolino I., Receputo G. Diabetes in the elderly: remarks from an epidemiological study carried out in a town in south-eastern Sicily (Militello V.C.). Acta Diabetol. 1990, 27:231-242.
37. Lyssenko V., Lupi R., Marchetti P., Del Guerra S., Orho-Melander M., Almgren P., Sjögren M., Ling C., Eriksson K.F., Lethagen A.L., Mancarella R., Berglund G., Tuomi T., Nilsson P., Del Prato S., Groop L. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Invest. 2007, 117:2155-2163.
38. Lyssenko V., Jonsson A., Almgren P., Pulizzi N., Isomaa B., Tuomi T., Berglund G., Altshuler D., Nilsson P., Groop L. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N. Engl. J. Med. 2008, 359:2220-2232.
39. McBean A.M., Li S., Gilbertson D.T., Collins A.J. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care 2004, 27:2317-2324.
40. Motta L., Carnazzo G. Senile Diabetes. Lecture at 95° Congress of Italian Society of Internal Medicine 1994, Pozzi, Rome, pp. 7-79.
41. Motta M., Bennati E., Cardillo E., Ferlito L., Passamonte M., Vacante M., Malaguarnera M. A combination of glycosylated hemoglobin, impaired fasting glucose and waist circumference is effective in screening for individuals at risk for future type 2 diabetes. Arch. Gerontol. Geriatr. 2010, 50:105-109.
42. Motta M., Bennati E., Capri M., Ferlito L., Malaguarnera M. Diabetes mellitus in the extreme longevity. Exp. Gerontol. 2008, 43:102-105.
43. Motta M., Bennati E., Ferlito L., Passamonte M., Malaguarnera M. Insulin-resistance (IR) in older age. Arch. Gerontol. Geriatr. 2008, 46:203-209.
44. Motta M., Bennati E., Ferlito L., Passamonte M., Cardillo E., Malaguarnera M. A review on the actual trends of insulin treatment in elderly with diabetes. Arch. Gerontol. Geriatr. 2008, 47:151-161.
45. Motta M., Bennati E., Cardillo E., Ferito L., Malaguarnera M. Pathogenesis of senile diabetes. Ind. J. Med. Res. 2008, 128:225-227.
46. Motta M., Bennati E., Ferlito L., Passamonte M., Malaguarnera M. Value and significance of new diagnostic criteria of diabetes mellitus in older people. Arch. Gerontol. Geriatr. 2007, 45:103-108.
47. Motta M., Bennati E., Ferlito L., Passamonte M., Branca S., Motta L., Malaguarnera M. Cardio-cerebrovascular complications in elderly with diabetes. Arch. Gerontol. Geriatr. 2007, 44:261-269.
48. Motta M., Malaguarnera M., Ferrari E., Mauro V.N., Ferrucci L., Rapisarda R., Tomasello F.B., Basile G., Ferlito L., Passamonte M., Bennati E. Genealogy of centenarians and their relatives: a study of 12 families. Arch. Gerontol. Geriatr. 2007, 45:97-102.
49. Motta M., Bennati E., Ferlito L., Malaguarnera M. Diabetes mellitus in the elderly: diagnostic features. Arch. Gerontol. Geriatr. 2006, 42:101-106.
50. NDDG (National Diabetes Data Group) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979, 28:1039-1057.
51. Pearson E.R., Donnelly L.A., Kimber C., Whitley A., Doney A.S., McCarthy M.I., Hattersley A.T., Morris A.D., Palmer C.N. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes 2007, 56:2178-2182.
52. Poulsen P., Grunnet L.G., Pilgaard K., Storgaard H., Alibegovic A., Sonne M.P., Carstensen B., Beck-Nielsen H., Vaag A. Increased risk of Type 2 diabetes in elderly twins. Diabetes 2009, 58:1350-1355.
53. Qu H.Q., Grant S.F., Bradfield J.P., Kim C., Frackelton E., Hakonarson H., Polychronakos C. Association analysis of type 2 diabetes Loci in type 1 diabetes. Diabetes 2008, 57:1983-1986.
54. Ravelli G.P., Stein Z.A., Susser M.W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 1976, 295:349-353.
55. Rijsewijk F., Schuermann M., Wagenaar E., Parren P., Weigel D., Nusse R. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 1987, 50:649-657.
56. Rosso D., Carnazzo G., Giarelli L., Motta L., Maugeri D. Atherosclerosis and pancreatic damage. Arch. Gerontol. Geriatr. 2001, 32:95-100.
57. Saxena R., Gianniny L., Burtt N.P., Lyssenko V., Giuducci C., Sjögren M., Florez J.C., Almgren P., Isomaa B., Orho-Melander M., Lindblad U., Daly M.J., Tuomi T., Hirschhorn J.N., Ardlie K.G., Groop L.C., Altshuler D. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895.
58. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I.W., Chen H., Roix J.J., Kathiresan S., Hirschhorn J.N., Daly M.J., Hughes T.E., Groop L., Altshuler D., Almgren P., Florez J.C., Meyer J., Ardlie K., Bengtsson Boström K., Isomaa B., Lettre G., Lindblad U., Lyon H.N., Melander O., Newton-Cheh C., Nilsson P., Orho-Melander M., Råstam L., Speliotes E.K., Taskinen M.R., Tuomi T., Guiducci C., Berglund A., Carlson J., Gianniny L., Hackett R., Hall L., Holmkvist J., Laurila E., Sjögren M., Sterner M., Surti A., Svensson M., Svensson M., Tewhey R., Blumenstiel B., Parkin M., Defelice M., Barry R., Brodeur W., Camarata J., Chia N., Fava M., Gibbons J., Handsaker B., Healy C., Nguyen K., Gates C., Sougnez C., Gage D., Nizzari M., Gabriel S.B., Chirn G.W., Ma Q., Parikh H., Richardson D., Ricke D., Purcell S., Diabetes Genetics Initiative of Broad Institute of Harvard MIT, Lund University, Novartis Institutes of BioMedical Research Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
59. Schinner S., Willenberg H.S., Schott M., Scherbaum W.A. Pathophysio-logical aspects of Wnt-signaling in endocrine disease. Eur. J. Endocrinol. 2009, 160:731-737.
60. Selvin E., Coresh J., Brancati F.L. The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 2006, 29:2415-2419.
61. Shu L., Matveyenko A.V., Kerr-Conte J., Cho J.H., McIntosh C.H., Maedler K. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum. Mol. Genet. 2009, 18:2388-2399.
62. Signorelli S., Motta L., Polosa P. Attualità in tema di diabete mellito umano. Arch. Med. Mutual. 1970, 58:1. (in Italian).
63. Smith U. TCF7L2 and type 2 diabetes-we WNT to know. Diabetologia 2007, 50:5-7.
64. Solerte S.B., Fioravanti M., Ferrari E. Clinical complexity of diabetes mellitus during old age. G. Gerontol. 2003, 51:431-435.
65. Sousa A.G., Marquezine G.F., Lemos P.A., Martinez E., Lopes N., Hueb W.A., Krieger J.E., Pereira A.C. TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PLoS One 2009, 174:e7697.
66. Stolerman E.S., Manning A.K., McAteer J.B., Fox C.S., Dupuis J., Meigs J.B., Florez J.C. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 2009, 52:614-620.
67. Tong Y., Lin Y., Zhang Y., Yang J., Zhang Y., Liu H., Zhang B. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large human genome epidemiology (HuGE) review and meta-analysis. BMC Med. Genet. 2009, 10:15.
68. Tong Z., Yang Z., Patel S., Chen H., Gibbs D., Yang X., Hau V.S., Kaminoh Y., Harmon J., Pearson E., Buehler J., Chen Y., Yu B., Tinkham N.H., Zabriskie N.A., Zeng J., Luo L., Sun J.K., Prakash M., Hamam R.N., Tonna S., Constantine R., Ronquillo C.C., Sadda S., Avery R.L., Brand J.M., London N., Anduze A.L., King G.L., Bernstein P.S., Watkins S., Genetics of Diabetes Diabetic Complication Study Group, Jorde L.B., Li D.Y., Aiello L.P., Pollak M.R., Zhang K. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6998-7003.
69. Von Naunyn, B., 1898. " Der Diabetes Mellitus" Vienna. In: Historiae illustreè du diabete de l'antiquitè a nos jours. R. Dacosta, Paris, 1987.
70. Welters H.J., Kulkarni R.N. Wnt signaling: relevance to beta-cell biology and diabetes. Trends Endocrinol. Metab. 2008, 19:349-355.
71. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes. Diabetes Care 2004, 27:1047-1053.
72. WHO (World Health Organization) WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series 1980, vol. 646:9-14. WHO, Geneva. 2nd ed.
73. Zeggini E., McCarthy M.I. TCF7L2: the biggest story in diabetes genetics since HLA?. Diabetologia 2007, 50:1-4.
74. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., De Bakker P.I., Becasis G.R., Almgren P., Andersen G., Ardlie K., Bostrom K.B., Bergman R.N., Bonnycastle L.L., Borch-Johnsen K., Burtt N.P., Chen H., Chines P.S., Daly M.J., Deodhar P., Ding C.J., Doney A.S., Duren W.L., Elliott K.S., Erdos M.R., Frayling T.M., Freathy R.M., Gianniny L., Grallert H., Grarup N., Groves C.J., Guiducci C., Hansen T., Herder C., Hitman G.A., Hughes T.E., Isomaa B., Jackson A.U., Jørgensen T., Kong A., Kubalanza K., Kuruvilla F.G., Kuusisto J., Langenberg C., Lango H., Lauritzen T., Li Y., Lindgren C.M., Lyssenko V., Marvelle A.F., Meisinger C., Midthjell K., Mohlke K.L., Morken M.A., Morris A.D., Narisu N., Nilsson P., Owen K.R., Palmer C.N., Payne F., Perry J.R., Pettersen E., Platou C., Prokopenko I., Qi L., Qin L., Rayner N.W., Rees M., Roix J.J., Sandbæk A., Shields B., Sjogren M., Steinthorsdottir V., Stringham H.M., Swift A.J., Thorleifsson G., Thorsteinsdottir U., Timpson N.J., Tuomi T., Tuomilehto J., Walker M., Watanabe R.M., Weedon M.N., Willer C.J., Wellcome Trust Case Control Consortium, Illig T., Hveem K., Hu F.B., Laakso M., Stefansson K., Pedersen O., Wareham N.J., Barroso I., Hattersley A.T., Collins F.S., Groop L., McCarthy M.I., Boehnke M., Altshuler D. Meta analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 2008, 40:635-645.